Remove Biosimilars Remove Seminar Remove Small Molecule
article thumbnail

Lab of the future uncovered at Tech Theatre, ELRIG Drug Discovery 2022

Drug Discovery World

She will be presenting a talk on ‘The lab of the future is now: Using AI or automation for the drug discovery process’ The Tech Theatre will feature a series of seminars focused on automation and technology for drug discovery. How can automation help the discovery of biologics and biosimilars? The sustainable lab.

article thumbnail

New to ELRIG Drug Discovery 2022: Tech Theatre supported by DDW

Drug Discovery World

A series of short seminars focused on automation and technology will be available to visitors at Drug Discovery 2022 which takes place at the ExCel, London 4 and 5 October. The seminars will be held in a dedicated Tech Theatre, centrally located in the exhibition hall. Product Manager, SPT Labtech. Fellowship Programme.

article thumbnail

Analysis Life Sciences Thank You FDA fiscal year in review: New drug approvals in the wake of the pandemic and legislative reforms

Agency IQ

For example, these products face a much more arduous path for development of biosimilar or interchangeable products than that of generics for small molecules. As AgencyIQ has previously discussed , developing biosimilars is an expensive process.

FDA 52